| Back to main Menu |
| Back to Additional Services |
61F1. Prescribed post-coital OCP
61A1. Morning after pills given
ga2B. LEVONORGESTREL 1.5mg tablets
ga2C. LEVONELLE ONE STEP 1.5mg tablet
ga2D. LEVONELLE 1500micrograms tablets
6147. Combined oral contraceptive
g8% COMBINED ORAL CONTRACEPTIVE - ETHINYLOESTRADIOL
g9% COMBINED ORAL CONTRACEPTIVE - MESTRANOL
gk : COMBINED ORAL CONTRACEPTIVE - ESTRADIOL VALERATE
(v17)
gk1 : DIENOGEST (COMBINED ORAL CONTRACEPTIVE) (v17)
gk11 : QLAIRA tablets (v17)
6148. Progestagen only oral contrac.
ga1% ETYNODIOL DIACETATE [PROGESTOGEN ORAL CONTRACEPTIVE]
ga22. NORGESTON tablets
ga23. LEVONORGESTREL 30micrograms tablets
ga5% NORETHISTERONE [PROGESTOGEN ORAL CONTRACEPTIVE]
ga8% DESOGESTREL [PROGESTOGEN ONLY CONTRACEPTIVE]
fh1q. ETHINYLESTRADIOL+NORELGESTROMIN 600micrograms/6mg transdermal patches
fh1r. EVRA transdermal patches
6161. CAP fitted
pg4% VAGINAL CAP CONTRACEPTIVE
pg5% VAGINAL DIAPHRAGM CONTRACEPTIVE
pgC% VAGINAL DIAPHRAGM CONTRACEPTIVE [2]
7E094 Introduction of Mirena coil
ga26. LEVONORGESTREL 52mg intrauterine system
ga27. MIRENA 52mg intrauterine system
6152. IUD removed
615B. IUD expelled
615Q. Intrauterine contraceptive device removed by other healthcare provider
7E092 Removal of intrauterine contraceptive device NEC
7E093 Removal of displaced intrauterine contraceptive device
7E095 Removal of Mirena coil
ga35. MEDROXYPROGESTERONE 150mg/1mL prefilled syringe
ga36. DEPO-PROVERA 150mg/1mL prefilled syringe
ga61. NORISTERAT 200mg/1mL injection
ga6z. NORETHISTERONE 200mg/1mL injection
9hK0. Excepted from sexual health quality indicators: patient unsuitable
9hK1. Excepted from sexual health quality indicators: informed dissent
Around 80% of (prescribed) contraception in the UK is provided in general practice.
The vast majority of practices are providing the additional service for contraception and many are also providing enhanced services including long acting reversible contraception (LARC) methods. All practices providing any level of contraception need to be able to advise women about all methods to ensure they can make an informed choice. Clinical staff in practices which are not providing all methods also need enough knowledge of these to refer appropriately those women who have chosen a method which they do not supply. Practices also should be aware of local services and local referral pathways.
Ref Respect & Responsibility A Sexual Health Strategy for Scotland. www.scotland.gov.uk/Resource/Doc/35596/0012575.pdf
NHS Quality Improvement Scotland Sexual Health Services – Standards March 2008. www.nhshealthquality.org/nhsqis/files/SEXHEALTHSERV_STANF_MAR08.pdf
This indicator set seeks to increase the awareness of women seeking contraceptive advice in general practices of LARC methods and thus to increase the percentage of women using these methods.
The practice can produce a register of women who have been prescribed any method of contraception at least once in the last year, or other appropriate interval e.g. last 5 years for an IUS.
General practices provide 80% of prescribed contraception in the UK. This register is applicable to all methods of contraception that have been prescribed by the practice:
• Emergency hormonal contraception
• Combined oral contraception
• Progestogen only oral contraception
• Contraceptive patch
• Contraceptive diaphragm
• Intrauterine device (IUD)
• Intrauterine system (IUS)
• Contraceptive implant.
Any woman who has been prescribed any method at least once in the last year (or the appropriate prescribing interval for method of choice) should be included on the register.
This indicator is prospective from 1 April 2009.
The practice reports the number of women prescribed any method of contraception in the preceding 1 April to 31 March (or longer if appropriate for the method of choice).
Prepared By Jean Keenan